|
|
|||||||||
Department of Radiology, Nuclear Medicine Service, and Gerschel PET Center, Memorial SloanKettering Cancer Center, New York, New York
PET/CT is a new imaging technology that has already found a number of clinical applications in oncologic imaging. Widespread introduction into clinical practice started approximately 2.5 years ago. Consequently, the available data are largely preliminary. Nevertheless, it can already be stated that the synthesis of structural and metabolic information improves the accuracy of primary staging and the detection of recurrent disease and has the realistic potential to change patient management in 10 to 20% of cases. PET/CT fusion images can directly guide biopsies or surgical interventions. This article summarizes preliminary data of PET/CT studies and highlights potential clinical applications for PET/CT, with particular emphasis on lymphoma, melanoma and gastrointestinal tumors.
Key Words: gastroenterology PET PET/CT cancer diagnostic imaging modalities
This article has been cited by other articles:
![]() |
A. M. Scott, D. H. Gunawardana, B. Kelley, J. G. Stuckey, A. J. Byrne, J. E. Ramshaw, and M. J. Fulham PET Changes Management and Improves Prognostic Stratification in Patients with Recurrent Colorectal Cancer: Results of a Multicenter Prospective Study J. Nucl. Med., September 1, 2008; 49(9): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Kurli, K Chin, and P T Finger Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma Br J Ophthalmol, April 1, 2008; 92(4): 479 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chatziioannou VP-PET: A New Imaging Modality? J. Nucl. Med., March 1, 2008; 49(3): 345 - 346. [Full Text] [PDF] |
||||
![]() |
A C Pfannenberg, P Aschoff, K Brechtel, M Muller, M Klein, R Bares, C D Claussen, and S M Eschmann Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging Br. J. Radiol., June 1, 2007; 80(954): 437 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S.P. Meirelles, Y. E. Erdi, S. A. Nehmeh, O. D. Squire, S. M. Larson, J. L. Humm, and H. Schoder Deep-Inspiration Breath-Hold PET/CT: Clinical Findings with a New Technique for Detection and Characterization of Thoracic Lesions J. Nucl. Med., May 1, 2007; 48(5): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Elaini, S. K. Shetty, V. M. Chapman, D. V. Sahani, G. W. Boland, A. T. Sweeney, M. M. Maher, J. T. Slattery, P. R. Mueller, and M. A. Blake Improved Detection and Characterization of Adrenal Disease with PET-CT RadioGraphics, May 1, 2007; 27(3): 755 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Czernin and H. R. Schelbert Introduction J. Nucl. Med., January 1, 2007; 48(1_suppl): 2S - 3S. [Full Text] [PDF] |
||||
![]() |
T. Z. Belhocine, A. M. Scott, E. Even-Sapir, J.-L. Urbain, and R. Essner Role of Nuclear Medicine in the Management of Cutaneous Malignant Melanoma J. Nucl. Med., June 1, 2006; 47(6): 957 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Y. Tsai, A. Taur, L. Espinosa, A. Quon, D. Johnson, S. Dick, S. Chow, R. Advani, R. Warnke, S. Kohler, et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol, May 1, 2006; 142(5): 577 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Raanani, Y. Shasha, C. Perry, U. Metser, E. Naparstek, S. Apter, A. Nagler, A. Polliack, I. Ben-Bassat, and E. Even-Sapir Is CT scan still necessary for staging in Hodgkin and non-Hodgkin lymphoma patients in the PET/CT era? Ann. Onc., January 1, 2006; 17(1): 117 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Krishnasetty, A. J. Fischman, E. L. Halpern, and S. L. Aquino Comparison of Alignment of Computer-registered Data Sets: Combined PET/CT versus Independent PET and CT of the Thorax Radiology, November 1, 2005; 237(2): 635 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Reinhardt, C. Herkel, C. Altehoefer, J. Finke, and E. Moser Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Ann. Onc., September 1, 2005; 16(9): 1524 - 1529. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Subhas, P. V. Patel, H. K. Pannu, H. A. Jacene, E. K. Fishman, and R. L. Wahl Imaging of Pelvic Malignancies with In-Line FDG PET-CT: Case Examples and Common Pitfalls of FDG PET RadioGraphics, July 1, 2005; 25(4): 1031 - 1043. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |